Reports
Reports
Sale
The global intravenous infusion pump market size was valued at USD 5.3 billion in 2023, driven by the rising prevalence of chronic diseases across the globe. The market is expected to grow at a CAGR of 7.6% during the forecast period of 2024-2032, with the values likely to rise from USD 5.7 billion in 2024 to USD 10.2 billion by 2032.
An intravenous infusion pump is a device used to administer medication or fluids into a patient's body for treating high blood pressure. They offer significant advantage over manual administration as it capable of delivering fluids at precisely programmed intervals and in smaller volumes as well.
Infusion pumps can be stationary or portable depending on the patient’s requirement. Some pumps are equipped with safety measures like an alarm clock or other operator alerts as well. They may be mechanically or electrically powered.
Intravenous infusion must be highly precise because even minute changes can threaten a patient's life. As a result, authorities like the FDA and EU continuously evaluate the efficacy of prevailing devices. To curb the high intravenous infusion pump market demand, prominent healthcare companies keep on bringing updated versions of devices.
Recently, FDA approved the redistribution of BD’s Alaris infusion pump in the market. This latest version is enabled with new software, hardware, and cybersecurity updates to deliver precise medications to the patients.
In August 2023, ICU Medical received 510(k) FDA clearance to its Plum Duo infusion pump, enabled with LifeShield infusion safety software. This pump features a large touch screen that enables an intuitive user interface as well. Similarly, Baxter’s Novum IQ syringe infusion pump (SYR) is paired with Dose IQ safety software that provides enhanced safety features, connectivity and a vast portfolio of sets designed to deliver optimum dose precision.
With a surge in innovations and digital integration into healthcare and medical devices, IOT (internet of things) controlled devices are set to emerge in the market. Researchers are working on developing remote monitoring enabled infusion pumps for accurate detection of patient’s vitals. Such technologies will enhance the intravenous infusion pump market growth in the upcoming years.
Market Breakup by Type
Market Breakup by Applications
Market Breakup by End User
Market Breakup by Region
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Applications |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Intravenous Infusion Pump Market Overview
3.1 Global Intravenous Infusion Pump Market Historical Value (2017-2023)
3.2 Global Intravenous Infusion Pump Market Forecast Value (2024-2032)
4 Global Intravenous Infusion Pump Market Landscape
4.1 Global Intravenous Infusion Pump: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Intravenous Infusion Pump: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Intravenous Infusion Pump Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Intravenous Infusion Pump Market Segmentation
6.1 Global Intravenous Infusion Pump Market by Type
6.1.1 Market Overview
6.1.2 Volumetric Infusion Pumps
6.1.3 Syringe Infusion Pumps
6.1.4 Patient Controlled Analgesia Infusion Pumps
6.2 Global Intravenous Infusion Pump Market by Applications
6.2.1 Market Overview
6.2.2 Oncology
6.2.3 Parenteral Nutrition
6.2.4 Analgesia/Pain Management
6.2.5 Others
6.3 Global Intravenous Infusion Pump Market by End User
6.3.1 Market Overview
6.3.2 Hospital and Clinics
6.3.3 Home Healthcare
6.3.4 Others
6.4 Global Intravenous Infusion Pump Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Intravenous Infusion Pump Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Intravenous Infusion Pump Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Intravenous Infusion Pump Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Intravenous Infusion Pump Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Intravenous Infusion Pump Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 F. Hoffmann-La Roche Ltd.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 Fresenius SE & Co. KGaA
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 B. Braun
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Becton, Dickinson and Company
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Baxter
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Terumo Corporation
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Medtronic Plc
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Smith Medical
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 ICU Medical
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Tandem Diabetes Care, Inc
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 5.3 billion in 2023, driven by the increasing incidence of chronic diseases across the globe.
The market is anticipated to grow at a CAGR of 7.6% during the forecast period of 2024-2032, likely to reach a market value of USD 10.2 billion by 2032.
The market demand has increased due to increased cases of chronic diseases, due to which patients have to undergo acute care facilities.
Infusion pumps enabled with cybersecurity have emerged in the market. In August 2023, ICU Medical gained 510(k) FDA clearance for their Plum Duo infusion pump, which is enabled with LifeShield infusion safety software. Baxter’s Novum IQ syringe infusion pump (SYR) is also paired with Dose IQ safety software to offer enhanced safety features, and connectivity.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Volumetric infusion pumps, syringe infusion pumps, and patient controlled analgesia infusion pumps are available in the market.
Major end users include home healthcare, hospital and clinics, among others.
Common application areas include oncology, parenteral nutrition, and analgesia/pain management, among others.
Key players involved in the market are F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, B. Braun, Becton, Dickinson and Company, Baxter, Terumo Corporation, Medtronic Plc, Smith Medical, ICU Medical and Tandem Diabetes Care, Inc.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.